Insider Selling: Phreesia, Inc. (NYSE:PHR) General Counsel Sells $60,961.50 in Stock

Phreesia, Inc. (NYSE:PHR) General Counsel Allison C. Hoffman sold 2,622 shares of the stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $23.25, for a total value of $60,961.50. Following the completion of the sale, the general counsel now owns 123,075 shares of the company’s stock, valued at approximately $2,861,493.75. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Phreesia Stock Up 3.9 %

NYSE PHR opened at $24.69 on Friday. Phreesia, Inc. has a 52 week low of $12.05 and a 52 week high of $29.16. The firm has a market capitalization of $1.42 billion, a price-to-earnings ratio of -11.38 and a beta of 0.93. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.03. The company has a fifty day moving average of $23.72 and a two-hundred day moving average of $22.73.

Hedge Funds Weigh In On Phreesia

A number of large investors have recently made changes to their positions in the company. Vanguard Group Inc. lifted its stake in Phreesia by 4.4% in the fourth quarter. Vanguard Group Inc. now owns 4,628,441 shares of the company’s stock worth $107,148,000 after purchasing an additional 194,035 shares during the last quarter. Champlain Investment Partners LLC bought a new stake in shares of Phreesia during the 1st quarter worth approximately $29,941,000. Brown Advisory Inc. boosted its holdings in Phreesia by 22.2% during the 4th quarter. Brown Advisory Inc. now owns 3,950,356 shares of the company’s stock valued at $91,451,000 after acquiring an additional 716,374 shares during the period. Boston Partners bought a new position in Phreesia in the 1st quarter valued at $669,000. Finally, Blair William & Co. IL increased its stake in Phreesia by 42.6% in the first quarter. Blair William & Co. IL now owns 752,700 shares of the company’s stock worth $18,012,000 after purchasing an additional 224,950 shares during the period. 92.10% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on PHR shares. KeyCorp reduced their price target on shares of Phreesia from $27.00 to $25.00 and set an “overweight” rating on the stock in a report on Thursday, July 11th. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $34.00 target price on shares of Phreesia in a report on Thursday, September 5th. Stephens reissued an “overweight” rating and set a $28.00 price target on shares of Phreesia in a research note on Friday, May 31st. Truist Financial raised their price target on Phreesia from $29.00 to $31.00 and gave the company a “buy” rating in a report on Friday, September 6th. Finally, Robert W. Baird upped their price objective on Phreesia from $31.00 to $34.00 and gave the stock an “outperform” rating in a report on Friday, September 6th. One equities research analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $29.42.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.